The largest database of trusted experimental protocols
Sourced in United States, Jamaica, Ireland, United Kingdom, Sweden

NONMEM is a software application used for population pharmacokinetic and pharmacodynamic (PK/PD) modeling and analysis. It is a tool for evaluating the relationship between drug dosing, drug concentrations, and drug effects in a population context.

Automatically generated - may contain errors

195 protocols using nonmem

1

NONMEM-based Time-to-Event Modeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
NONMEM® (version 7.4.3, ICON Development Solutions, Ellicott City, MD, USA)
29 was used for TTE modeling, with the Laplacian method used for parameter estimation.
30 (link) Visual Predictive Checks (VPCs) were simulated via Pearl‐speaks‐NONMEM® (version 4.8.1).
31 (link) Model selection was based on significant changes in the NONMEM® objective function value (OFV; p‐value <0.05), precision of parameter estimation (relative standard error (RSE) < 50%), and VPC inspection. VPC simulations used 1000 dataset replicates to assess observed versus model‐predicted 95% confidence intervals (CI). R (version 3.6.3, The R Foundation for Statistical Computing, Vienna, Austria) was used for visualization and statistical evaluation. In addition to the evaluation of the final model performance on the retained test dataset, a five‐fold cross validation was performed to address bias, potential overfitting, and parameter stability (for detailed information see Supplementary Methods 1.2 Cross validation). The analysis plan, along with subsequent post hoc steps, is illustrated in Figure 1.
+ Open protocol
+ Expand
2

Pharmacokinetic Modeling of First-in-Human Trials

Check if the same lab product or an alternative is used in the 5 most similar protocols
Simulations of the FIH design were undertaken using NONMEM version 7.1.2 (ICON Development Solutions), and the Metrum software package version 5.05 within R (MetrumRG, Metrum Research Group).
Cynomolgus monkey data were analyzed using NONMEM version 7.1.2 (ICON Development Solutions). FIH data were analyzed by nonlinear mixed‐effects modeling, with the FOCE method, using NONMEM version 7.3 (ICON Development Solutions).
Graphs of the simulations from monkey‐to‐human, and the overlay of human data, were undertaken using R. VPCs were run using Perl‐speaks NONMEM (PsN) for monkey VPCs (version 3.2.12) and FIH VPCs (version 4.2.0).21, 22 VPC graphs were generated using the xpose 423 package in R.
+ Open protocol
+ Expand
3

Nonlinear Mixed-Effects Modelling Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nonlinear mixed‐effects modelling was performed using NONMEM (version 7.3.0, ICON development Solutions, Ellicott City, MD, USA) and Pearl‐speaks‐NONMEM (PsN, version 4.7.0) with First‐Order Conditional Estimation with interaction (FOCE‐I) as estimation method.19 (link), 20 Pirana (version 2.9.9) was used as graphical user interface for NONMEM.21 (link) R (version 3.4.3) was used for data handling and visualization.22
+ Open protocol
+ Expand
4

Population PK Modeling and Simulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LD/CD measurements that were below limit of detection (5.6%) were handled using the M6 method [18 (link)], where LOD/2 is assigned to the first value and subsequent samples below LOD were deleted. The population PK model was developed using non-linear mixed effect modeling software NONMEM [19 ] (version 7.3; Icon Development Solutions, Ellicott City, MD, USA, 2009) using the first-order conditional estimation method (FOCE) with INTERACTION and a user-defined model (ADVAN6 NONMEM Subroutine). PsN [17 (link)] (version 4.7.0; Department of Pharmaceutical Biosciences, Uppsala University) was used for running models, simulating data, and testing covariate-parameter relations. R [20 ] (version 3.2.3; R Foundation for Statistical Computing) and Xpose [17 (link)] (version 4.5.0; Department of Pharmaceutical Biosciences, Uppsala University) were used for data management and graphical evaluation.
+ Open protocol
+ Expand
5

Exposure-Response Modeling for Dosing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Population pharmacokinetic (PPK) modeling and exposure–response (E‐R) modeling were utilized to support dosing recommendations. The analysis was carried out using NONMEM (Version 7.3, ICON Development Solutions) on workstations with Intel® Core™ i7 processors, Windows 7 Professional and the GNU gfortran compiler (Version 4.5.0, NONMEM7/compilers">http://ftp.globomaxnm.com/Public/NONMEM7/compilers). Post‐processing of NONMEM analysis results was carried out in R version 3.2.2. The stepwise covariate modeling (SCM) was carried out using Perl‐speaks‐NONMEM (PsN), version 4.2.0. Model development was carried out using first order conditional estimation with Interaction (FOCE‐I).
Initial development of PK/PD models was based on single‐ and multiple dose data inclusive of results in 144 healthy subjects. These patients were obtained from 12 clinical studies (Table 2). These PK/PD models were utilized to guide phase 3 study design. Upon completion of phase 3 studies, the PK/PD models were expanded to include the phase 3 study data with the results reported here.
+ Open protocol
+ Expand
6

Population Pharmacokinetic Modeling Using NONMEM

Check if the same lab product or an alternative is used in the 5 most similar protocols
PopPK analysis was conducted by non-linear mixed-effects modeling using NONMEM® (7.4, ICON Development Solutions, Ellicott City, Maryland, USA). NONMEM® was accessed through PsN (4.6.0, Uppsala University, Sweden) and run on a Linux high-performance cluster. Tables and figures were prepared with R version 3.3.1 or above (http://www.r-project.org). PsN 4.6.0 and Xpose 4.5.3 (Uppsala University, Sweden) were used as supportive software for NONMEM®. In addition, R package ‘mrgsolve’ (0.8.0 or above, Metrum Research Group LLC, CT) was used for simulation.
+ Open protocol
+ Expand
7

Bayesian Forecasting Using NONMEM and R

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bayesian forecasting was performed using NONMEM version 7.4.3 (ICON Development Solutions, Ellicott City, MD), and Perl‐speaks‐NONMEM version 4.8.1 was used for NONMEM run control.37, 38 Data management and graphical analyses were performed using R 3.5.1 (http://www.rproject.org/).
+ Open protocol
+ Expand
8

Nonlinear Mixed Effect Modeling for Pharmacokinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Modeling was performed using a Dell Power Edge R910 server with 4 × 10 core Xeon 2.26 Ghz processors running Windows Server 2008 R2 Enterprise 64‐bit. Model development used nonlinear mixed effect modeling using NONMEM (version 7.3; ICON Development Solutions, Ellicott City, MD)10 with the Wings for NONMEM (version 7.3) interface (http://wfn.sourceforge.net) and IFort compiler. Processing NONMEM output and generating plots was conducted with R Software version 3.1.1 or later11 using ggplot2, plyr, and scales packages12, 13, 14 and associated dependencies.
+ Open protocol
+ Expand
9

Nonlinear Mixed Effects Modeling for Interindividual Variability

Check if the same lab product or an alternative is used in the 5 most similar protocols
To take the interindividual variability into account, model development was performed using nonlinear mixed effects modeling, and the software NONMEM (version 7.3 by ICON Development Solutions, Ellicott City, MD) with the ADVAN 13 subroutine was used.24 Estimations were made by maximizing the likelihood of the data, using the stochastic approximation expectation maximization algorithm followed by importance sampling to obtain the objective function value for hypothesis testing.
The simultaneous modeling of continuous and count data was permitted in NONMEM by the indication variable F_FLAG.24 The delay, representing the CTC lifespan, was implemented in NONMEM with the Absorption LAG (ALAG) parameter and was calculated with the method of steps that allowed virtually solving a delay differential equations system by transforming it into an ordinary differential equations system.25 (link) Gamma and factorial functions were calculated using the GAMLN function implemented in NONMEM 7.3.24 Finally, data handling and graphical representations were performed in R, using the PsN suite and the Xpose package.26 (link)–28
+ Open protocol
+ Expand
10

Nonlinear Mixed-Effects Pharmacokinetic Modeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed the PPK analysis through nonlinear mixed-effects modeling with NONMEM® (version 7, Level 2, Icon Development Solutions, Ellicott City, MD, USA). Subroutine ADVAN 2 and first-order conditional estimation with interaction option (FOCE-I) method were used in modeling. PsN (version 3.4.2, Uppsala University, Sweden) was applied for model construction and validation. The diagnostic plots of NONMEM® outputs were conducted using R version 4.0.5 (http://www.r-project.org).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!